The baseline circulating immunophenotype characteristics associate with PD(L)-1 targeted treatment response, irae onset, and prognosis

Xiaomin Fu(Henan Cancer Hospital), Quanli Gao(Henan Cancer Hospital), Baozhen Ma(Henan Cancer Hospital), Jinrong Qu(Memorial Sloan Kettering Cancer Center), Lingdi Zhao(Zhengzhou University), Hongqin You(Henan Cancer Hospital), Yonghao Yang(Army Medical University), Fang Zhang(Shanghai First People's Hospital), Yiman Shang(Henan Cancer Hospital), Benling Xu(Zhengzhou University), Peng Qin(Shenzhen Bay Laboratory), Lu Han, Tingjie Wang(Zhengzhou University), Zibing Wang(Henan Cancer Hospital), Yong Zhang(Zhengzhou University), Fanghui Li(Henan Cancer Hospital)
Scientific Reports
May 20, 2025
Cited by 8


Related Papers